Decisio Health

Decisio Health is a Houston-based digital health company that offers a clinical decision support platform designed to aggregate and prioritize real-time patient data from various sources and present it visually in a single place. Their flagship product, InsightIQ, utilizes continuous smart bedside monitoring to enable clinical teams to efficiently identify at-risk patients and comply with established clinical guidelines. InsightIQ improves patient outcomes, optimizes workflow, increases collaboration, reduces length of stay, and alleviates "click fatigue."

InsightIQ is a decision support device that aggregates, displays, and manages physiological and other patient information generated by third-party medical devices and patient information systems. The software performs automated calculations on patient data collected by third-party devices based on approved clinical protocols at patient care facilities. It is designed to display patient information, facility-specific care protocols, and visual cues to care providers on a single display device, receiving data through the facility's Electronic Medical Record system.

In March 2022, Decisio Health appointed Major General Elder Granger to its board of directors to leverage his expertise in the healthcare industry. The company closed an USD 18.5 million Series B funding round in February 2022, bringing the total funds raised to USD 31.5 million since its founding in 2013. In May 2022, Decisio Health gained a patent (US Patent 11,309,079B2) related to a system, method, and computer program product for providing a patient dashboard system in a hospital setting. The company also rebranded, with the InsightIQ product previously known as DECISIOInsight.

In September 2022, Decisio Health received the Houston Business Journal's Innovation Awards, recognizing its innovative approach to improving patient outcomes and reducing costs through digitized bundles of care.